# Neuroprotective Role of Erythropoietin in Perinatal Asphyxia

> **NCT02002039** · PHASE2,PHASE3 · COMPLETED · sponsor: **Sheri Kashmir Institute of Medical Sciences** · enrollment: 100 (actual)

## Conditions studied

- Perinatal Asphyxia

## Interventions

- **DRUG:** Erythropoietin

## Key facts

- **NCT ID:** NCT02002039
- **Lead sponsor:** Sheri Kashmir Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02002039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02002039, "Neuroprotective Role of Erythropoietin in Perinatal Asphyxia". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT02002039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*